Patents by Inventor James R. Myette

James R. Myette has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODY MOLECULES TO CD138 AND USES THEREOF
    Publication number: 20190100588
    Abstract: Antibody molecules that specifically bind to CD138 are disclosed. The antibody molecules can be used to treat, prevent, and/or diagnose disorders, such as multiple myeloma.
    Type: Application
    Filed: October 2, 2018
    Publication date: April 4, 2019
    Inventors: Bharat Chaganty, Boopathy Ramakrishnan, Hedy Adari-Hall, Karthik Viswanathan, James R. Myette, Zachary Shriver
  • ANTIBODY MOLECULES TO APRIL AND USES THEREOF
    Publication number: 20190092851
    Abstract: Antibody molecules that specifically bind to APRIL are disclosed. The antibody molecules can be used to treat, prevent, and/or diagnose disorders, such as IgA nephropathy.
    Type: Application
    Filed: December 7, 2018
    Publication date: March 28, 2019
    Inventors: James R. Myette, Zachary Holmes Shriver, Karthik Viswanathan, Andrew M. Wollacott, Hedy Adari-Hall, Boopathy Ramakrishnan, Gregory Babcock
  • Antibody molecules to dengue virus and uses thereof
    Patent number: 10155806
    Abstract: Antibody molecules that specifically bind to dengue virus are disclosed. In certain embodiments, the antibody molecule bind to dengue virus serotypes DV-1, DV-2, DV-3, and DV-4. The antibody molecules can be used to treat, prevent, and/or diagnose dengue virus.
    Type: Grant
    Filed: May 16, 2016
    Date of Patent: December 18, 2018
    Assignee: VISTERRA, INC.
    Inventors: Luke Robinson, Zachary Shriver, James R. Myette, Gregory Babcock, Karthik Viswanathan
  • ANTIBODY MOLECULES TO APRIL AND USES THEREOF
    Publication number: 20170145086
    Abstract: Antibody molecules that specifically bind to APRIL are disclosed. The antibody molecules can be used to treat, prevent, and/or diagnose disorders, such as IgA nephropathy.
    Type: Application
    Filed: November 23, 2016
    Publication date: May 25, 2017
    Inventors: James R. Myette, Zachary Holmes Shriver, Karthik Viswanathan, Andrew M. Wollacott, Hedy Adari-Hall, Boopathy Ramakrishnan, Gregory Babcock
  • ANTIBODY MOLECULES TO DENGUE VIRUS AND USES THEREOF
    Publication number: 20160251413
    Abstract: Antibody molecules that specifically bind to dengue virus are disclosed. In certain embodiments, the antibody molecule bind to dengue virus serotypes DV-1, DV-2, DV-3, and DV-4. The antibody molecules can be used to treat, prevent, and/or diagnose dengue virus.
    Type: Application
    Filed: May 16, 2016
    Publication date: September 1, 2016
    Inventors: Luke Robinson, Zachary Shriver, James R. Myette, Gregory Babcock, Karthik Viswanathan
  • Compositions of and methods of using sulfatases from
    Patent number: 8846363
    Abstract: This invention is related, in part, to sulfatase enzymes and methods of their use.
    Type: Grant
    Filed: October 22, 2010
    Date of Patent: September 30, 2014
    Inventors: James R. Myette, Ram Sasisekharan
  • DELTA 4, 5 GLYCURONIDASE COMPOSITIONS AND METHODS RELATED THERETO
    Publication number: 20120045425
    Abstract: The invention relates to ?4,5 glycuronidase, related compositions, and methods of use thereof.
    Type: Application
    Filed: April 8, 2011
    Publication date: February 23, 2012
    Applicant: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
    Inventors: JAMES R. MYETTE, ZACHARY SHRIVER, GANESH VENKATARAMAN, RAM SASISEKHARAN, MAITLAND W. MCLEAN
  • Delta 4,5 glycuronidase compositions and methods related thereto
    Patent number: 7951560
    Abstract: The invention relates to ?4,5 glycuronidase, related compositions, and methods of use thereof.
    Type: Grant
    Filed: November 11, 2009
    Date of Patent: May 31, 2011
    Assignee: Massachusetts Institute of Technology
    Inventors: James R. Myette, Zachary Shriver, Ganesh Venkataraman, Ram Sasisekharan, Maitland W. McLean
  • COMPOSITIONS OF AND METHODS OF USING SULFATASES FROM FLAVOBACTERIUM HEPARINUM
    Publication number: 20110033901
    Abstract: This invention is related, in part, to sulfatase enzymes and methods of their use.
    Type: Application
    Filed: October 22, 2010
    Publication date: February 10, 2011
    Applicant: Massachusetts Institute of Technology
    Inventors: James R. Myette, Ram Sasisekharan
  • Compositions of and methods of using sulfatases from flavobacterium heparinum
    Patent number: 7842492
    Abstract: This invention is related, in part, to sulfatase enzymes and methods of their use.
    Type: Grant
    Filed: January 4, 2008
    Date of Patent: November 30, 2010
    Assignee: Massachusetts Institute of Technology
    Inventors: James R. Myette, Ram Sasisekharan
  • DELTA 4,5 GLYCURONIDASE COMPOSITIONS AND METHODS RELATED THERETO
    Publication number: 20100129868
    Abstract: The invention relates to ?4,5 glycuronidase, related compositions, and methods of use thereof.
    Type: Application
    Filed: November 11, 2009
    Publication date: May 27, 2010
    Applicant: Massachusetts Institute of Technology
    Inventors: James R. Myette, Zachary Shriver, Ganesh Venkataraman, Ram Sasisekharan, Maitland W. McLean
  • ? 4,5 glycuronidase nucleic acid compositions
    Patent number: 7695711
    Abstract: The invention relates to ?4,5 glycuronidase, related compositions, and methods of use thereof.
    Type: Grant
    Filed: April 11, 2006
    Date of Patent: April 13, 2010
    Assignee: Massachusetts Institute of Technology
    Inventors: James R. Myette, Zachary Shriver, Ganesh Venkataraman, Ram Sasisekharan, Maitland W. McLean
  • Compositions of and methods of using sulfatases from flavobacterium heparinum
    Publication number: 20090269326
    Abstract: This invention is related, in part, to sulfatase enzymes and methods of their use.
    Type: Application
    Filed: January 4, 2008
    Publication date: October 29, 2009
    Applicant: Massachusetts Institute of Technology
    Inventors: James R. Myette, Ram Sasisekharan
  • 2-O sulfatase compositions and methods of analyzing therewith
    Patent number: 7429474
    Abstract: The invention relates to 2-O sulfatase and uses thereof. In particular, the invention relates to recombinantly produced 2-O sulfatase, functional variants and nucleic acid molecules that encode these molecules. The invention also provides methods of using 2-O sulfatase for a variety of purposes, including degrading and analyzing glycosaminoglycans (GAGs) present in a sample. For instance, 2-O sulfatase may be used for determining the purity, identity, composition and sequence of glycosaminoglycans present in a sample. The invention also relates to methods of inhibiting angiogenesis and cellular proliferation as well as methods for treating cancer, neurodegenerative disease, atherosclerosis and microbial infection using 2-O sulfatase and/or GAG fragments produced by degradation with 2-O sulfatase.
    Type: Grant
    Filed: May 11, 2006
    Date of Patent: September 30, 2008
    Assignee: Massachusetts Institute of Technology
    Inventors: Ram Sasisekharan, James R. Myette, Zachary Shriver, Ganesh Venkataraman
  • 2-O sulfatase compositions and related methods
    Patent number: 7270815
    Abstract: The invention relates to 2-O sulfatase and uses thereof. In particular, the invention relates to recombinantly produced 2-O sulfatase, functional variants and nucleic acid molecules that encode these molecules. The invention also provides methods of using 2-O sulfatase for a variety of purposes, including degrading and analyzing glycosaminoglycans (GAGs) present in a sample. For instance, 2-O sulfatase may be used for determining the purity, identity, composition and sequence of glycosaminoglycans present in a sample. The invention also relates to methods of inhibiting angiogenesis and cellular proliferation as well as methods for treating cancer, neurodegenerative disease, atherosclerosis and microbial infection using 2-O sulfatase and/or GAG fragments produced by degradation with 2-O sulfatase.
    Type: Grant
    Filed: January 7, 2004
    Date of Patent: September 18, 2007
    Assignee: Massachusetts Institute of Technology
    Inventors: Ram Sasisekharan, James R. Myette, Zachary Shriver, Ganesh Venkataraman
  • 2-O sulfatase compositions and methods of hydrolyzing therewith
    Patent number: 7247445
    Abstract: The invention relates to 2-O sulfatase and uses thereof. In particular, the invention relates to recombinantly produced 2-O sulfatase, functional variants and nucleic acid molecules that encode these molecules. The invention also provides methods of using 2-O sulfatase for a variety of purposes, including degrading and analyzing glycosaminoglycans (GAGs) present in a sample. For instance, 2-O sulfatase may be used for determining the purity, identity, composition and sequence of glycosaminoglycans present in a sample. The invention also relates to methods of inhibiting angiogenesis and cellular proliferation as well as methods for treating cancer, neurodegenerative disease, atherosclerosis and microbial infection using 2-O sulfatase and/or GAG fragments produced by degradation with 2-O sulfatase.
    Type: Grant
    Filed: May 11, 2006
    Date of Patent: July 24, 2007
    Assignee: Massachusetts Institute of Technology
    Inventors: Ram Sasisekharan, James R. Myette, Zachary Shriver, Ganesh Venkataraman
  • Delta 4, 5 glycuronidase and uses thereof
    Publication number: 20040091471
    Abstract: The invention relates to &Dgr;4,5 glycuronidase, related compositions, and methods of use thereof.
    Type: Application
    Filed: May 5, 2003
    Publication date: May 13, 2004
    Inventors: James R. Myette, Zachary Shriver, Ganesh Venkataraman, Ram Sasisekharan, Maitland W. McLean